Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 1, 2003, Pages 85-95

  Engler, Henry ^a   Lundberg, Per Olov ^a   Ekbom, Karl ^b   Nennesmo, Inger ^b   Nilsson, Anna ^a   Bergström, Mats ^a   Tsukada, Hideo ^c   Hartvig, Per ^a   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Astrocytosis; Creutzfeldt Jakob disease; Deprenyl; FDG; Positron emission tomography

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; GLUCOSE; MONOAMINE OXIDASE INHIBITOR; N METHYL LEVO DEUTERODEPRENYL C 11; OXYGEN 15; PRION PROTEIN; UNCLASSIFIED DRUG; WATER;

ADULT; AGED; ARTICLE; ASTROCYTOSIS; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; MALE; NERVE CELL NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; SJOEGREN SYNDROME; TEMPORAL CORTEX; TEMPORAL LOBE;

ADULT; AGED; BRAIN; CARBON RADIOISOTOPES; CEREBROVASCULAR CIRCULATION; CREUTZFELDT-JAKOB SYNDROME; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLIOSIS; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; OXYGEN RADIOISOTOPES; RADIOISOTOPES; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0038207690     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-1008-x     Document Type: Article

References (34)

1. Meyer MA, Hubner KF, Raja S, Hunter K, Paulsen WA. Sequential positron emission tomographic evaluations of brain metabolism in acute herpes encephalitis. J Neuroimaging 1994; 4:104-105.
2. Provenzale JM, Barboriak DP, Coleman RE. Limbic encephalitis: comparison of FDG PET and MR imaging findings. AJR Am J Roentgenol 1998; 170:1659-1660.
3. Weiner SM, Otte A, Schumacher M, et al. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 2000; 9:386-389.
4. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123:1481-1494.
5. Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I. Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 2001; 25:274-277.
6. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224-233.
7. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55:811-815.
8. Green AJ, Thompson EJ, Stewart GE, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70:744-748.
9. Jacobs DA, Lesser RL, Mourelatos Z, Galetta SL, Balcer LJ. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol 2001; 21:99-102.
10. Stenstrom A, Arai Y, Oreland L. Intra- and extraneuronal monoamineoxidase-A and -B activities after central axotomy (hemisection) on rats. J Neural Transm 1985; 61:105-113.
11. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 1990; 80:419-425.
12. Ekblom J, Jossan SS, Bergstrom M, Oreland L, Walum E, Aquilonius SM. Monoamine oxidase-B in astrocytes. Glia 1993; 8:122-132.
13. 11C-labelled L-deprenyl. J Neural Transm 1989; 77:55-64.
14. 3H]deprenyl. Brain Res 1991; 547:69-76.
15. Holte S, Eriksson L, Dahlbom M. A preliminary evaluation of the Scanditronix PC2048-15B brain scanner. Eur J Nucl Med 1989; 15:719-721.
16. Andersson JL, Thurfjell L. Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans. J Comput Assist Tomogr 1997; 21:136-144.
17. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7.
18. 11C-L-deuterium-deprenyl - analysis of kinetic data. Acta Neurol Scand 1998; 98:224-231.
19. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28:897-916.
20. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371-388.
21. 15)O. II. Implementation and validation. J Nucl Med 1983; 24:790-798.
22. Mathews D, Unwin DH. Quantitative cerebral blood flow imaging in a patient with the Heidenhain variant of Creutzfeldt-Jakob disease. Clin Nucl Med 2001; 26:770-773.
23. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PET scan. Seizure 1999; 8:427-431.
24. 18F]-2-fluorodeoxyglucose. J Comput Assist Tomogr 1984; 8:978-981.
25. Goldman S, Laird A, Flament-Durand J, et al. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Neurology 1993; 43:1828-1830.
26. Matochik JA, Molchan SE, Zametkin AJ, Warden DL, Sunderland T, Cohen RM. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease. Acta Neurol Scand 1995; 91:153-157.
27. Alkire MT, Haier RJ, Barker SJ, Shah NK, Wu JC, Kao YJ. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology 1995; 82:393-403; discussion 327A.
28. Vandesteene A, Trempont V, Engelman E, et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988; 43 Suppl:42-43.
29. Van Hemelrijck J, Fitch W, Mattheussen M, Van Aken H, Plets C, Lauwers T. Effect of propofol on cerebral circulation and autoregulation in the baboon. Anesth Analg 1990; 71: 49-54.
30. Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, MacGregor R. Age related increases in brain monoamine oxidase B in living healthy subjects. Neurobiol Aging 1997; 4:431-435.
31. Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001; 56: 726-739.
32. Molloy S, O'Laoide R, Brett F, Farrell M. The "pulvinar" sign in variant Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2000; 175:555-556.
33. 11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. Brain Res 1994; 663:191-198.
34. 2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain. J Neurosci 2000; 20:7067-7073.